Cargando…
Case Report: PsAPSASH syndrome: an alternative phenotype of syndromic hidradenitis suppurativa treated with the IL-17A inhibitor secukinumab
Syndromic hidradenitis suppurativa (HS) is a form of symptom constellations, which differs from the familial and genetic form and comprises predominantly osteoarticular manifestations. Many forms include pyoderma gangrenosum and acne (PASH), pyogenic arthritis (PAPASH), spondyloarthritis (PASS) and...
Autores principales: | Nikolakis, Georgios, Kreibich, Katja, Vaiopoulos, Aristeidis, Kaleta, Katarzyna, Talas, Joud, Becker, Markus, Zouboulis, Christos C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424462/ https://www.ncbi.nlm.nih.gov/pubmed/34540202 http://dx.doi.org/10.12688/f1000research.52100.2 |
Ejemplares similares
-
Secukinumab and hidradenitis suppurativa: Friends or foes?
por: Marasca, Claudio, et al.
Publicado: (2019) -
Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa
por: Gulliver, Wayne, et al.
Publicado: (2016) -
A Case of Moderate Hidradenitis Suppurativa and Psoriasis Treated with Secukinumab
por: Giuseppe, Pistone, et al.
Publicado: (2018) -
Review of Comorbidities of Hidradenitis Suppurativa: Implications for Daily Clinical Practice
por: Tzellos, Thrasyvoulos, et al.
Publicado: (2020) -
An Integrated Approach to Unravel Hidradenitis Suppurativa Etiopathogenesis
por: Tricarico, Paola M., et al.
Publicado: (2019)